Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprotinin vs EACA in Aortic Valve Surgery
NCT00156520Phase 4Completed
- Sponsor
- University of Rochester
- Start
- Mar 2005
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of aprotinin in hemorrhage (2 arms), sponsored by University of Rochester. Primary endpoints: Platelet Function Analyzer-100 Closure Time, von Willebrand Factor Antigen and 3 more. Started Mar 2005; status: completed.
02
Drugs
aprotinin
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT00156520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00156520.